Premature ovarian failure is a condition in which the ovaries stop functioning normally before age 40, leading to irregular or absent periods, reduced estrogen levels, and difficulty getting pregnant. The preferred medical term today is primary ovarian insufficiency (POI), because “failure” implies the ovaries have shut down completely, when in reality they often still function intermittently. About 1 in 100 women under 40 is affected, and the condition can develop as early as the teenage years.
Why the Name Changed
You may see both “premature ovarian failure” and “primary ovarian insufficiency” used interchangeably, but they carry different implications. “Failure” suggests the ovaries have permanently stopped working. In practice, ovarian function in this condition tends to fluctuate. Some women still ovulate occasionally and produce estrogen at unpredictable intervals. The term “insufficiency” better captures this variability and is now standard in clinical guidelines from organizations like the American College of Obstetricians and Gynecologists (ACOG).
How It Feels
The hallmark sign is a change in your menstrual cycle. Periods may become irregular, less frequent, or stop altogether. Because the ovaries produce less estrogen, many women experience symptoms that overlap with menopause: hot flashes, night sweats, vaginal dryness, pain during sex, difficulty sleeping, and trouble concentrating. These symptoms can appear gradually or arrive suddenly, depending on how quickly ovarian function declines.
Some women first notice something is off when they have trouble conceiving. Others are caught off guard by hot flashes in their twenties or thirties, well before they’d expect anything menopause-related. The emotional weight of the diagnosis can be significant on its own, which is covered further below.
Known Causes
In most cases, no clear cause is found. When a cause can be identified, it typically falls into a few categories:
- Genetic conditions. Turner syndrome (where one X chromosome is missing or incomplete) and Fragile X premutation are among the most common genetic links. Women who carry the Fragile X premutation are at significantly higher risk even if they don’t have Fragile X syndrome itself.
- Autoimmune disorders. The immune system sometimes attacks ovarian tissue. Women with POI have higher rates of other autoimmune conditions, particularly thyroid disease and adrenal insufficiency (Addison disease).
- Medical treatments. Chemotherapy, radiation therapy targeting the pelvic area, and certain ovarian surgeries can damage ovarian tissue enough to trigger the condition.
- Toxins and infections. Exposure to certain chemicals or viral infections has been linked to ovarian damage in some cases, though this is less common.
How It Is Diagnosed
Diagnosis requires two things: menstrual irregularity lasting at least three consecutive months, and elevated levels of follicle-stimulating hormone (FSH) confirmed on two separate blood tests taken at least one month apart. FSH is the hormone your brain releases to signal the ovaries to produce eggs. When the ovaries aren’t responding properly, the brain keeps increasing FSH output, pushing levels into the menopausal range, typically above 30 to 40 mIU/mL depending on the lab.
Before settling on a POI diagnosis, other causes of missed or irregular periods need to be ruled out. These include pregnancy, thyroid problems, high prolactin levels, polycystic ovary syndrome, and hypothalamic amenorrhea (where the brain temporarily stops signaling the ovaries, often related to stress, low body weight, or excessive exercise). Blood tests for estradiol are also drawn alongside FSH to confirm that estrogen levels are low.
Long-Term Health Risks
POI is not just a reproductive issue. Estrogen plays a protective role throughout the body, and losing it early raises several health concerns that extend well beyond fertility.
Cardiovascular disease is the most serious long-term risk. Women with POI who don’t receive hormone therapy have a reduced life expectancy, largely because of higher rates of coronary artery disease, heart failure, and stroke. Estrogen helps maintain healthy blood vessel function, and losing it decades early removes that protection for a longer stretch of life.
Bone health takes a hit as well. Estrogen is essential for maintaining bone density, and women with POI develop abnormal bone structure and reduced bone mineral density at younger ages. This translates to a higher risk of osteoporosis and fractures later in life. Reduced muscle mass and strength are also associated with the condition, compounding fall and fracture risk as women age.
There is also growing evidence linking POI to an increased risk of cognitive impairment and dementia. The connection is still being studied, but the pattern is consistent enough that it is now included in clinical guidelines from the American Society for Reproductive Medicine.
Treatment With Hormone Therapy
The cornerstone of treatment is hormone therapy to replace the estrogen (and progesterone, if you have a uterus) that the ovaries are no longer reliably producing. This is different from hormone therapy prescribed to older women going through natural menopause. For women with POI, the goal is to restore hormones to the levels your body would normally have at your age, not to add hormones on top of normal production. This distinction matters because the risk-benefit calculation is very different for a 30-year-old replacing missing hormones than for a 55-year-old supplementing declining ones.
Hormone therapy can be taken orally or through a skin patch. Both routes are considered first-line options. For women who also need contraception (since spontaneous ovulation is still possible), a hormonal IUD can provide the progesterone component while also preventing pregnancy. Hormone therapy is generally recommended until at least age 50 or 51, the average age of natural menopause, to reduce the cardiovascular, bone, and cognitive risks described above.
Fertility After Diagnosis
One of the most difficult aspects of a POI diagnosis for many women is the impact on fertility. The condition significantly reduces the chance of natural conception, but it does not eliminate it entirely. Around 5% to 10% of women with POI become pregnant spontaneously without fertility treatment. This happens because ovarian function can flicker on and off unpredictably, occasionally producing a viable egg.
For women who want to become pregnant and don’t conceive on their own, egg donation combined with in vitro fertilization is the most reliable option. There is no proven treatment that consistently restores ovarian function or improves egg production in women with established POI, though research in this area is active.
Emotional and Psychological Impact
The psychological toll of POI is substantial and often underestimated. In a study published in The Journal of Clinical Endocrinology & Metabolism, 54.5% of women with POI had experienced major depression at some point in their lives, significantly higher than rates seen in the general population. A lifetime history of any mood disorder was present in 67% of women with the condition.
Interestingly, the relationship between POI and depression is not simply a reaction to the diagnosis. Among women who experienced major depression, about 74% reported their first depressive episode after the onset of menstrual changes but before they received a formal diagnosis. This suggests that the hormonal disruption itself may contribute to mood changes, not just the emotional distress of learning about the condition. At the time of the study, 22% of participants met criteria for a current psychiatric diagnosis, most commonly a mood disorder.
The grief associated with POI can be layered: loss of fertility, loss of a “normal” timeline, and the burden of managing a chronic condition at a young age. These feelings are a normal response to a genuinely difficult situation, and mental health support is a meaningful part of comprehensive care.